Table 1

Characteristics of Physicians With a Drug Enforcement Agency Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder, by Prescribing Category

CharacteristicOverallNever a PrescriberFormer PrescriberaCurrent Prescriber Not Accepting New PatientsbCurrent Prescriber Accepting New PatientscP Valued
Age, y
 <35, %
 36–55, %41.037.341.944.440.8
 56–65, %34.140.735.629.833.2
 >65, %21.215.318.823.422.5
Sex, male, %75.179.769.872.676.4.157
 Northeast, %24.123.420.830.224.0
 Midwest, %20.427.422.316.319.3
 South, %
 West, %21.416.118.327.922.1
 Family medicine, %43.335.537.146.546.0
 Psychiatry, %18.629.824.416.315.3
 Internal medicine, %10.35.612.715.59.5
 Other, %27.829.025.921.729.2
Practice type, private, %38.621.520.651.743.5<.001
Waiver type<.001
 30 patients, %55.893.577.755.042.6
 100 patients, %44.26.522.345.057.4
  • Note: Percentages within categories may not total 100 because of rounding. Missing data: age, n = 47; sex, n = 42; practice type, n = 243.

  • a Have prescribed buprenorphine, but not currently treating patients, or accepting new opioid use disorder patients.

  • b Have prescribed buprenorphine, and currently treating patients, but not accepting new opioid use disorder patients (may or may not have reached the patient limit of their waiver).

  • c Currently treating patients, and accepting new opioid use disorder patients.

  • d Overall 4-category χ2 test.